Skip to content

EFFICACY And TOLLERABILITY Of TREATMENT for inhalation WITH L-ASA IN PATIENTS WITH MILD Or MODERATED ASTHMA IN COMPARISON WITH CORTICOSTEROID for inhalation

EFFICACY And TOLLERABILITY Of TREATMENT for inhalation WITH L-ASA IN PATIENTS WITH MILD Or MODERATED ASTHMA IN COMPARISON WITH CORTICOSTEROID for inhalation

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
EU CTR
Registry ID
EUCTR2005-001808-40-IT
Enrollment
160
Registered
2005-08-24
Start date
2005-08-04
Completion date
Unknown
Last updated
2012-08-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

TREATMENT of MILD Or MODERATED ASTHMA MedDRA version: 6.1 Level: PT Classification code 10003553

Interventions

Product Name: NA Product Code: NA Pharmaceutical Form: Nebuliser solution CAS Number: 34220-70-7 Other descriptive name: acetyl-salycilic acid Concentration unit: mg milligram(s) Concentration type: e

Sponsors

MEDESTEA RESEARCH & PRODUCTION
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Are the trial subjects under 18? no Number of subjects for this age range: F.1.2 Adults (18-64 years) yes F.1.2.1 Number of subjects for this age range F.1.3 Elderly (>=65 years) no F.1.3.1 Number of subjects for this age range

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Main Objective: ;Secondary Objective: ;Primary end point(s):

Countries

Italy

Outcome results

None listed

Source: EU CTR (via WHO ICTRP) · Data processed: Feb 4, 2026